_id
6915f20ebc934aba376b210d
Ticker
RVPHW
Name
Reviva Pharmaceuticals Holdings Inc
Exchange
NASDAQ
Address
10080 N. Wolfe Road, Cupertino, CA, United States, 95014
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.revivapharma.com
Description
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Last Close
0.0036
Volume
196408
Current Price
0.003
Change
-16.666666666666664
Last Updated
2025-12-03T13:11:48.554Z
Image
data:image/webp;base64,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
Ipo Date
2018-10-18T00:00:00.000Z
Market Cap
85814050
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4029841
Operating Income
-4029841
Interest Expense
2605
Pretax Income
-4007933
Net Income
-4010773
Eps
-0.041632685735598966
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-34590
Cash
13183259
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
13512928
Property Plant Equipment
-
Total Assets
14332649
Payables
5431806
Short Term Debt
-
Long Term Debt
-
Total Liabilities
9782914
Equity
4549735
Depreciation
-
Change In Working Capital
-2064908
Cash From Operations
-5589486
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
8409031
Net Change In Cash
2819545
PE
-
PB
0.06352267923296631
ROE
-88.15399138631152
ROA
-27.98347325745576
FCF
-5589486
Fcf Percent
-
Piotroski FScore
0
Health Score
27
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4029841
Quarters > 0 > income Statement > operating Income
-4029841
Quarters > 0 > income Statement > interest Expense
2605
Quarters > 0 > income Statement > pretax Income
-4007933
Quarters > 0 > income Statement > net Income
-4010773
Quarters > 0 > income Statement > eps
-0.041632685735598966
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
96337119
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-34590
Quarters > 0 > balance Sheet > cash
13183259
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
13512928
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
14332649
Quarters > 0 > balance Sheet > payables
5431806
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9782914
Quarters > 0 > balance Sheet > equity
4549735
Quarters > 0 > cash Flow > net Income
-4010773
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-2064908
Quarters > 0 > cash Flow > cash From Operations
-5589486
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
8409031
Quarters > 0 > cash Flow > net Change In Cash
2819545
Quarters > 0 > ratios > PE
-0.041632685735598966
Quarters > 0 > ratios > PB
0.06352267923296631
Quarters > 0 > ratios > ROE
-88.15399138631152
Quarters > 0 > ratios > ROA
-27.98347325745576
Quarters > 0 > ratios > FCF
-5589486
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6072982
Quarters > 1 > income Statement > operating Income
-6072982
Quarters > 1 > income Statement > interest Expense
4797
Quarters > 1 > income Statement > pretax Income
-6045656
Quarters > 1 > income Statement > net Income
-6053610
Quarters > 1 > income Statement > eps
-0.1214416936393995
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
49847872
Quarters > 1 > income Statement > income Tax Expense
7954
Quarters > 1 > income Statement > EBITDA
-6040859
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
27326
Quarters > 1 > balance Sheet > cash
10363714
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10815125
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
11634846
Quarters > 1 > balance Sheet > payables
4968688
Quarters > 1 > balance Sheet > short Term Debt
113246
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
12093993
Quarters > 1 > balance Sheet > equity
-459147
Quarters > 1 > cash Flow > net Income
-6053610
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
656711
Quarters > 1 > cash Flow > cash From Operations
-5012748
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
10087058
Quarters > 1 > cash Flow > net Change In Cash
5074310
Quarters > 1 > ratios > PE
-0.1214416936393995
Quarters > 1 > ratios > PB
-0.32569877620892657
Quarters > 1 > ratios > ROE
1318.4470333030597
Quarters > 1 > ratios > ROA
-52.02999678723723
Quarters > 1 > ratios > FCF
-5012748
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
6538167
Quarters > 2 > income Statement > operating Income
-6538167
Quarters > 2 > income Statement > interest Expense
11620
Quarters > 2 > income Statement > pretax Income
-6427627
Quarters > 2 > income Statement > net Income
-6432840
Quarters > 2 > income Statement > eps
-0.13224231497934424
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
48644339
Quarters > 2 > income Statement > income Tax Expense
5213
Quarters > 2 > income Statement > EBITDA
-6416007
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
110540
Quarters > 2 > balance Sheet > cash
5289404
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
6257325
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
7077046
Quarters > 2 > balance Sheet > payables
4721043
Quarters > 2 > balance Sheet > short Term Debt
224300
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11537070
Quarters > 2 > balance Sheet > equity
-4460024
Quarters > 2 > cash Flow > net Income
-6432840
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-2619283
Quarters > 2 > cash Flow > cash From Operations
-8194198
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
7271
Quarters > 2 > cash Flow > net Change In Cash
-8186927
Quarters > 2 > ratios > PE
-0.13224231497934424
Quarters > 2 > ratios > PB
-0.032720231326109454
Quarters > 2 > ratios > ROE
144.2333045741458
Quarters > 2 > ratios > ROA
-90.89724724129248
Quarters > 2 > ratios > FCF
-8194198
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
6284606
Quarters > 3 > income Statement > operating Income
-6284606
Quarters > 3 > income Statement > interest Expense
4711
Quarters > 3 > income Statement > pretax Income
-6254744
Quarters > 3 > income Statement > net Income
-6259477
Quarters > 3 > income Statement > eps
-0.13438352600266912
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
46579199
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-12840
Quarters > 3 > balance Sheet > cash
13476331
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
14683367
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
15503088
Quarters > 3 > balance Sheet > payables
6283430
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
14690516
Quarters > 3 > balance Sheet > equity
812572
Quarters > 3 > cash Flow > net Income
-6259480
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-3406362
Quarters > 3 > cash Flow > cash From Operations
-9100497
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
17018011
Quarters > 3 > cash Flow > net Change In Cash
7917514
Quarters > 3 > ratios > PE
-0.13438352600266912
Quarters > 3 > ratios > PB
0.17196949562623373
Quarters > 3 > ratios > ROE
-770.3289062384625
Quarters > 3 > ratios > ROA
-40.37567870349443
Quarters > 3 > ratios > FCF
-9100497
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
30798889
Annuals > 0 > income Statement > operating Income
-30798889
Annuals > 0 > income Statement > interest Expense
18497
Annuals > 0 > income Statement > pretax Income
-29899288
Annuals > 0 > income Statement > net Income
-29918802
Annuals > 0 > income Statement > eps
-0.9025981023442425
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
33147424
Annuals > 0 > income Statement > income Tax Expense
19514
Annuals > 0 > income Statement > EBITDA
-29880795
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
899601
Annuals > 0 > balance Sheet > cash
13476331
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
14683367
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
15503088
Annuals > 0 > balance Sheet > payables
6283430
Annuals > 0 > balance Sheet > short Term Debt
458154
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
14690516
Annuals > 0 > balance Sheet > equity
812572
Annuals > 0 > cash Flow > net Income
-29918802
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-4537810
Annuals > 0 > cash Flow > cash From Operations
-33543916
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
23652791
Annuals > 0 > cash Flow > net Change In Cash
-9891125
Annuals > 0 > ratios > PE
-0.9025981023442425
Annuals > 0 > ratios > PB
0.43240807509980655
Annuals > 0 > ratios > ROE
-3681.987811541623
Annuals > 0 > ratios > ROA
-192.98608122459214
Annuals > 0 > ratios > FCF
-33543916
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
39503636
Annuals > 1 > income Statement > operating Income
-39503636
Annuals > 1 > income Statement > interest Expense
33725
Annuals > 1 > income Statement > pretax Income
-39243888
Annuals > 1 > income Statement > net Income
-39260837
Annuals > 1 > income Statement > eps
-1.6497395622686302
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
23798203
Annuals > 1 > income Statement > income Tax Expense
16949
Annuals > 1 > income Statement > EBITDA
-39503636
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
39503596.76
Annuals > 1 > balance Sheet > cash
23367456
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
23700388
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
23700388
Annuals > 1 > balance Sheet > payables
3849108
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
17981672
Annuals > 1 > balance Sheet > equity
5718716
Annuals > 1 > cash Flow > net Income
-39260837
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
7283914
Annuals > 1 > cash Flow > cash From Operations
-28324353
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
33171953
Annuals > 1 > cash Flow > net Change In Cash
4847600
Annuals > 1 > ratios > PE
-1.6497395622686302
Annuals > 1 > ratios > PB
0.04411146694467779
Annuals > 1 > ratios > ROE
-686.5323789466026
Annuals > 1 > ratios > ROA
-165.6548280981729
Annuals > 1 > ratios > FCF
-28324353
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
24306608
Annuals > 2 > income Statement > operating Income
-24306608
Annuals > 2 > income Statement > interest Expense
182802
Annuals > 2 > income Statement > pretax Income
-24318515
Annuals > 2 > income Statement > net Income
-24339292
Annuals > 2 > income Statement > eps
-1.2471149124798586
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19516479
Annuals > 2 > income Statement > income Tax Expense
20777
Annuals > 2 > income Statement > EBITDA
-24111899
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-11907
Annuals > 2 > balance Sheet > cash
18519856
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
18923675
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
18923675
Annuals > 2 > balance Sheet > payables
3520271
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6607279
Annuals > 2 > balance Sheet > equity
12316396
Annuals > 2 > cash Flow > net Income
-24339292
Annuals > 2 > cash Flow > depreciation
194709
Annuals > 2 > cash Flow > change In Working Capital
5007267
Annuals > 2 > cash Flow > cash From Operations
-18960581
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
7792493
Annuals > 2 > cash Flow > net Change In Cash
-11168088
Annuals > 2 > ratios > PE
-1.2471149124798586
Annuals > 2 > ratios > PB
0.01679668933996601
Annuals > 2 > ratios > ROE
-197.61699769965176
Annuals > 2 > ratios > ROA
-128.61820972934697
Annuals > 2 > ratios > FCF
-18960581
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
10104513
Annuals > 3 > income Statement > operating Income
-10104513
Annuals > 3 > income Statement > interest Expense
2414
Annuals > 3 > income Statement > pretax Income
-8515872
Annuals > 3 > income Statement > net Income
-8521876
Annuals > 3 > income Statement > eps
-0.5761589112939675
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
14790843
Annuals > 3 > income Statement > income Tax Expense
6004
Annuals > 3 > income Statement > EBITDA
-8513458
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1588641
Annuals > 3 > balance Sheet > cash
29687944
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
31404000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
31404000
Annuals > 3 > balance Sheet > payables
509583
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2717541
Annuals > 3 > balance Sheet > equity
28686460
Annuals > 3 > cash Flow > net Income
-8521876
Annuals > 3 > cash Flow > depreciation
107
Annuals > 3 > cash Flow > change In Working Capital
-702173
Annuals > 3 > cash Flow > cash From Operations
-10668462
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
31595944
Annuals > 3 > cash Flow > net Change In Cash
20927482
Annuals > 3 > ratios > PE
-0.5761589112939675
Annuals > 3 > ratios > PB
0.005465398512050633
Annuals > 3 > ratios > ROE
-29.706962797082664
Annuals > 3 > ratios > ROA
-27.136275633677236
Annuals > 3 > ratios > FCF
-10668462
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.041632685735598966
Valuation > metrics > PB
0.06352267923296631
Valuation > final Score
70
Valuation > verdict
93.6% Undervalued
Profitability > metrics > ROE
-88.15399138631152
Profitability > metrics > ROA
-29.68100621863744
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.1502162213843223
Risk > metrics > Interest Coverage
-1546.963915547025
Risk > final Score
-6170
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.4877412779469665
Liquidity > metrics > Quick Ratio
2.4877412779469665
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
15
Prev Risks > 0
-5034
Prev Risks > 1
-2221
Prev Risks > 2
-5330
Prev Liquidities > 0
100
Prev Liquidities > 1
82
Prev Liquidities > 2
100
Updated At
2026-01-20T22:30:48.243Z
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGrowth Recap: Can Associated Capital Group Inc continue delivering strong returns - 2025 Winners & Losers & Intraday High Probability Alerts baoquankhu1.vn
Read more →Investor Mood: Whats the RSI of LDTCW stock - 2025 Major Catalysts & Verified Momentum Watchlists baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Reviva Pharmaceuticals Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.